BHC (STOCKS)
Bausch Health Companies Inc
$5.600000
+0.000000 (+0.00%)
Prev close: $5.600000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Thomas J. Appio
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,129.92M
- Employees
- 20,700
- P/E (TTM)
- 13.37
- P/B (TTM)
- -3.75
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
5
Hold
3
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.10 | $1.28 | -0.1771 | -13.87% |
|
Sep 2025 (Q3)
|
$1.16 | $1.13 | +0.0293 | +2.59% |
|
Jun 2025 (Q2)
|
$0.91 | $0.98 | -0.0692 | -7.07% |
|
Mar 2025 (Q1)
|
$0.60 | $0.80 | -0.2014 | -25.13% |
Financial Statements
| Revenues | $10.27B |
| Benefits Costs and Expenses | $9.90B |
| Costs And Expenses | $8.45B |
| Operating Expenses | $8.45B |
| Selling, General, and Administrative Expenses | $3.44B |
| Depreciation and Amortization | $1.21B |
| Other Operating Expenses | $3.81B |
| Operating Income/Loss | $1.81B |
| Income/Loss From Continuing Operations After Tax | $120.00M |
| Income/Loss From Continuing Operations Before Tax | $367.00M |
| Income Tax Expense/Benefit | $247.00M |
| Income Tax Expense/Benefit, Current | $115.00M |
| Income Tax Expense/Benefit, Deferred | $132.00M |
| Net Income/Loss | $120.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$37.00M |
| Net Income/Loss Attributable To Parent | $157.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $157.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.42 |
| Diluted Earnings Per Share | $0.42 |
| Basic Average Shares | 370,900,000 |
| Diluted Average Shares | 375,000,000 |
| Assets | $26.37B |
| Current Assets | $6.16B |
| Accounts Receivable | $2.35B |
| Inventory | $1.63B |
| Other Current Assets | $2.18B |
| Noncurrent Assets | $20.21B |
| Fixed Assets | $2.07B |
| Intangible Assets | $4.64B |
| Other Non-current Assets | $13.49B |
| Liabilities | $25.99B |
| Current Liabilities | $4.18B |
| Accounts Payable | $600.00M |
| Other Current Liabilities | $3.58B |
| Noncurrent Liabilities | $21.81B |
| Long-term Debt | $20.82B |
| Other Non-current Liabilities | $992.00M |
| Equity | $377.00M |
| Equity Attributable To Noncontrolling Interest | $931.00M |
| Equity Attributable To Parent | -$554.00M |
| Liabilities And Equity | $26.37B |
| Net Cash Flow From Operating Activities | $1.40B |
| Net Cash Flow From Operating Activities, Continuing | $1.40B |
| Net Cash Flow From Investing Activities | -$595.00M |
| Net Cash Flow From Investing Activities, Continuing | -$595.00M |
| Net Cash Flow From Financing Activities | -$742.00M |
| Net Cash Flow From Financing Activities, Continuing | -$742.00M |
| Exchange Gains/Losses | $61.00M |
| Net Cash Flow | $124.00M |
| Net Cash Flow, Continuing | $63.00M |
| Comprehensive Income/Loss | $516.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$60.00M |
| Comprehensive Income/Loss Attributable To Parent | $576.00M |
| Other Comprehensive Income/Loss | $396.00M |